Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 7/20 | 0.42 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.38 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.38 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.36 |
| ▸ | PSEN2 | P49810 | 3/20 | 0.36 |
| ▸ | APH1B | Q8WW43 | 3/20 | 0.36 |
| ▸ | NCSTN | Q92542 | 3/20 | 0.36 |
| ▸ | APH1A | Q96BI3 | 3/20 | 0.36 |
| ▸ | PSENEN | Q9NZ42 | 3/20 | 0.36 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | JAK1 | P23458 | 1/20 | 0.36 |
| ▸ | JAK3 | P52333 | 1/20 | 0.36 |
| ▸ | STK17B | O94768 | 3/20 | 0.35 |
| ▸ | STK17A | Q9UEE5 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KCNQ3 | O43525 | 2/20 | 0.32 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.32 |
| ▸ | KCNQ5 | Q9NR82 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15836879 | 1.00 | NTRK1 (0.42) | NTRK1MAP4K1ROCK2ROCK1PSEN1 | |
| SCHEMBL14670674 | 0.91 | ALDH1A1 (0.40) | NTRK1MAP4K1ROCK2ROCK1PSEN1 | |
| SCHEMBL14670591 | 0.88 | USP1 (0.39) | NTRK1MAP4K1ROCK2ROCK1PSEN1 | |
| SCHEMBL14662723 | 0.85 | NTRK1 (0.39) | NTRK1ALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL14662726 | 0.85 | NTRK1 (0.39) | NTRK1ALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL4619629 | 0.82 | NTRK1 (0.58) | NTRK1MAP4K1STK17BSTK17AALDH1A1 | |
| SCHEMBL14670569 | 0.82 | NTRK1 (0.58) | NTRK1MAP4K1STK17BSTK17AALDH1A1 | |
| SCHEMBL14670399 | 0.81 | CYP2C19 (0.38) | NTRK1STK17BSTK17A | |
| SCHEMBL14670525 | 0.81 | NTRK1 (0.44) | NTRK1MAP4K1ROCK2ROCK1MAPK1 | |
| SCHEMBL14670408 | 0.81 | NTRK1 (0.44) | NTRK1MAP4K1ROCK2ROCK1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140179664-A1 | Heterocyclyl Pyrimidine Analogues As JAK Inhibitors | CELLZOME LIMITED (GB) | 2014-06-26 | — | — | US | disclosed |
| US-20140179664-A1 | Heterocyclyl Pyrimidine Analogues As JAK Inhibitors | CELLZOME LIMITED (GB) | 2014-06-26 | — | — | US | disclosed |
| WO-2013014162-A1 | HETEROCYCLYL PYRIMIDINE ANALOGUES AS JAK INHIBITORS | CELLZOME LIMITED (GB) | 2013-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179664-A1 | Heterocyclyl Pyrimidine Analogues As JAK Inhibitors | JAK1, JAK3, JAK2 | NTRK1 4690/4885MAP4K1 529/4885ROCK2 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.